Becton Dickinson & Co. said Wednesday that it will receive $42 million from the U.S. government to build out manufacturing capacity for vaccine injection devices, to be used during the coronavirus pandemic. The Biomedical Advanced Research and Development Authority awarded the funding as part of Operation Warp Speed, a Trump administration program aimed at having 300 million doses of a COVID-19 vaccine in January. BD, which says it is the largest manufacturer of injection devices in the world, said the total cost of the capital project is $70 million. BD’s stock is down 7.5% since the start of the year, while the S&P 500 has declined 2.6%.
- Chief Executive’s blog – Parole Board Covid-19 recovery plan
- Birmingham dealmakers complete sale of manufacturer to listed international firm | TheBusinessDesk.com